mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
mRNA |
thapsigargin |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0002 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
mRNA |
Elesclomol |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
mRNA |
indisulam |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0002 |
mRNA |
Vinblastine |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
mRNA |
FH535 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
mRNA |
hyperforin |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |